TB500 (Thymosin Beta) – 10mg

TB-500 (Thymosin Beta-4) 10mg protocols focus on this synthetic peptide fragment of the naturally occurring protein Thymosin Beta-4, studied for its potential role in tissue repair, inflammation modulation, and recovery enhancement. TB-500 is believed to support cellular migration and angiogenesis, which may contribute to faster healing of muscles, tendons, ligaments, and connective tissues. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical weekly range: 2–10 mg per week (split dosing)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks

Concise summary of the subcutaneous regimen.

  • Goal: Support tissue repair, reduce inflammation, and enhance recovery
  • Schedule: 1–3 injections per week or split into smaller doses across the week
  • Dose Range: 2–10 mg per week, depending on recovery needs

Suggested approach for the 10 mg vial format.

  • Start: 2 mg per week to assess tolerance
  • Target: 5–10 mg per week based on recovery demand
  • Frequency: 1–3 times per week (subcutaneous or near injury site)
  • Vial Duration: One 10 mg vial lasts approximately 1–5 weeks, depending on dosing
  • Timing: Flexible; often used consistently during recovery phases

TB-500 (Thymosin Beta-4 fragment) is a synthetic peptide derived from a naturally occurring protein involved in cell structure and repair. It plays a key role in actin regulation, which is essential for cell movement, tissue regeneration, and wound healing.

By promoting cellular migration and angiogenesis (formation of new blood vessels), TB-500 may enhance the body’s ability to repair damaged tissues. It is also studied for its potential anti-inflammatory effects and ability to support recovery in muscles, tendons, ligaments, and other connective tissues. Preclinical research suggests it may accelerate healing and improve flexibility and mobility in injury models.

Observations based on preclinical and early research.

Potential Benefits:

  • May support faster recovery from soft tissue injuries
  • May reduce inflammation and stiffness
  • May improve flexibility and range of motion
  • May support connective tissue repair and regeneration

Possible Side Effects:

  • Mild fatigue or temporary lethargy
  • Injection-site irritation
  • Headache in some cases
  • Long-term human safety data are limited; it remains investigational